| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $17.4M | -3.2% | -34.1% |
| SG&A Expense | $5.1M | -6.6% | -16.5% |
| Operating Income | -$22.5M | +15.4% | +30.8% |
| Interest Expense | $408K | +0.7% | -8.5% |
| Net Income | -$22.1M | +14.7% | +27.9% |
| EPS (Basic) | -$0.41 | +16.3% | +29.3% |
| EPS (Diluted) | -$0.41 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.4M | +21.4% | +45.6% |
| Short-term Investments | $37.2M | -38.0% | -71.9% |
| Current Assets | $66.5M | -22.0% | -57.3% |
| Total Assets | $82.7M | -13.2% | -55.5% |
| Current Liabilities | $27.7M | +47.1% | -14.3% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.2M | — | — |
| Capital Expenditures | $163K | — | — |
| Investing Cash Flow | $71.4M | — | — |
| Financing Cash Flow | -$316K | — | — |
| Free Cash Flow | -$65.3M | — | — |
| +16.3% |
| +29.3% |
| $10.6M |
| +0.0% |
| +0.0% |
| Total Liabilities | $37.9M | +22.7% | -22.5% |
| Stockholders' Equity | $44.8M | -30.5% | -67.3% |